SEI Investments
ALLO icon

SEI Investments’s Allogene Therapeutics ALLO Stock Holding History

SEI Investments’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Buy
51,952
+3,632
+8% +$7.28K ﹤0.01% 3054
2025
Q4 		$66.2K Hold
48,320
– – ﹤0.01% 3055
2025
Q3 		$59.9K Hold
48,320
– – ﹤0.01% 2765
2025
Q2 		$54.6K Hold
48,320
– – ﹤0.01% 2744
2025
Q1 		$70.5K Hold
48,320
– – ﹤0.01% 2647
2024
Q4 		$103K Buy
+48,320
New +$119K ﹤0.01% 2578
2022
Q4 		– Sell
-13,864
Closed -$150K – 2521
2022
Q3 		$150K Buy
13,864
+1,227
+10% +$16.7K ﹤0.01% 2513
2022
Q2 		$144K Buy
+12,637
New +$112K ﹤0.01% 2526
2020
Q3 		– Sell
-8,950
Closed -$383K – 2399
2020
Q2 		$383K Buy
+8,950
New +$324K ﹤0.01% 1971

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return